178 related articles for article (PubMed ID: 30689833)
1. Anti-Candida activity of beneficial vaginal lactobacilli in in vitro assays and in a murine experimental model.
De Gregorio PR; Silva JA; Marchesi A; Nader-Macías MEF
FEMS Yeast Res; 2019 Mar; 19(2):. PubMed ID: 30689833
[TBL] [Abstract][Full Text] [Related]
2. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME; Betsi GI; Athanasiou S
J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections.
De Gregorio PR; Tomás MSJ; Terraf MCL; Nader-Macías MEF
J Med Microbiol; 2014 May; 63(Pt 5):685-696. PubMed ID: 24523160
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
6. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
[TBL] [Abstract][Full Text] [Related]
7. [Role of Lactobacillus as protector against vaginal candidiasis].
Osset J; García E; Bartolomé RM; Andreu A
Med Clin (Barc); 2001 Sep; 117(8):285-8. PubMed ID: 11571120
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
[TBL] [Abstract][Full Text] [Related]
11. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans.
Jang SJ; Lee K; Kwon B; You HJ; Ko G
Sci Rep; 2019 May; 9(1):8121. PubMed ID: 31148560
[TBL] [Abstract][Full Text] [Related]
12. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
[TBL] [Abstract][Full Text] [Related]
13. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus fermentum Ess-1 with unique growth inhibition of vulvo-vaginal candidiasis pathogens.
Rönnqvist D; Forsgren-Brusk U; Husmark U; Grahn-Håkansson E
J Med Microbiol; 2007 Nov; 56(Pt 11):1500-1504. PubMed ID: 17965352
[TBL] [Abstract][Full Text] [Related]
15. Vaginal prevention of Candida albicans: synergistic effect of lactobacilli and mannan oligosaccharides (MOS).
Faustino M; Pereira JO; Pereira AM; Oliveira AS; Ferreira CMH; Pereira CF; Durão J; Pintado ME; Carvalho AP
Appl Microbiol Biotechnol; 2024 Dec; 108(1):73. PubMed ID: 38194142
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of vaginal
Takano T; Kudo H; Eguchi S; Matsumoto A; Oka K; Yamasaki Y; Takahashi M; Koshikawa T; Takemura H; Yamagishi Y; Mikamo H; Kunishima H
Front Cell Infect Microbiol; 2023; 13():1113401. PubMed ID: 37201113
[TBL] [Abstract][Full Text] [Related]
17. Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model.
De Gregorio PR; Juárez Tomás MS; Leccese Terraf MC; Nader-Macías ME
J Appl Microbiol; 2015 Apr; 118(4):1034-47. PubMed ID: 25786121
[TBL] [Abstract][Full Text] [Related]
18. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.
Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR
Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285
[TBL] [Abstract][Full Text] [Related]
19. A molecular view on the interference established between vaginal Lactobacilli and pathogenic Candida species: Challenges and opportunities for the development of new therapies.
Pedro NA; Mira NP
Microbiol Res; 2024 Apr; 281():127628. PubMed ID: 38246122
[TBL] [Abstract][Full Text] [Related]
20. Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.
Oerlemans EFM; Bellen G; Claes I; Henkens T; Allonsius CN; Wittouck S; van den Broek MFL; Wuyts S; Kiekens F; Donders GGG; Lebeer S
Sci Rep; 2020 May; 10(1):7976. PubMed ID: 32409699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
